Hydrocortisone Clinical Trial
The investigators aim to investigate the association between hair, serum, urine and saliva to measure cortisol, cortisone, cotinine, nicotine, melatonin and caffeine.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years to 40 Years |
Eligibility |
Inclusion Criteria: - adult volunteer Exclusion Criteria: - students of the study host - people who have steroid or melatonin medicine |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University Hospital | Test1 | Test2 |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Chinese Health Questionnaire (CHQ) | 5 minutes | Yes | |
Primary | Hospital Anxiety and Depression Scale (HADS) | 5 minutes | Yes | |
Primary | Pittsburgh Sleep Quality Index (PSQI) | 5 minutes | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05293652 -
Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar
|
N/A | |
Completed |
NCT04605198 -
Mindfulness-based Intervention to Address PTSD in Trauma-exposed, Homeless Women
|
N/A | |
Recruiting |
NCT03896659 -
Exploring the Effects of Corticosteroids on the Human Hippocampus
|
Phase 4 | |
Completed |
NCT04359147 -
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
|
N/A | |
Recruiting |
NCT05160506 -
Corticosteroids to Treat Pancreatitis
|
Phase 2 | |
Recruiting |
NCT05818826 -
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
|
Phase 2 | |
Terminated |
NCT02360046 -
The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids in Patients With Corticotropic Hypopituitarism
|
N/A | |
Completed |
NCT03718234 -
Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
|
Phase 1 |